Portola Pharma
About PTLA
Portola Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics in the areas of thrombosis, other hematologic disorders and inflammation for patients having limited or no approved treatment options. The Company's two lead programs, Betrixaban and Andexanet alfa, address unmet medical needs in the area of thrombosis, or blood clots. Its third product candidate is Cerdulatinib. The Company's Syk is a mediator of immune response in various types of immune cells. The Company has a program of selective Syk inhibitors, one of which is partnered with Ora Inc. Betrixaban is an oral once-daily inhibitor of Factor Xa in development for extended duration venous thromboembolism (VTE) prophylaxis in acute medically ill patients. Andexanet alfa is an orphan drug, which is a recombinant protein designed to reverse anticoagulant activity in patients treated with an fXa inhibitor.


Alexion completes acquisition of Portola Pharma; SEC charges with FCPA violations
Seeking Alpha - Article · 07/02 13:29
Portola Pharmaceuticals Inc (PTLA): Hedge Funds Are Cashing Out
Insider Monkey · 06/24 15:36
Rigrodsky & Long, P.A. Files Class Action Suit Against Portola Pharmaceuticals, Inc.
GlobeNewswire · 06/18 04:30
Alexion Pharmaceuticals: Patent Resolution Is Too Little Too Late
Seeking Alpha - Article · 06/10 18:44
SHAREHOLDER ALERT: WeissLaw LLP Reminds QUMU, TCO, PTLA, and WLTW Shareholders About Its Ongoing Investigations
GlobeNewswire · 06/05 22:24
KLXE, TORC, TERP, and PTLA SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
GlobeNewswire · 06/04 15:15
Lifshitz Law Firm, P.C. Announces Investigation of Franklin Financial Network, Inc., Mobile Mini, Inc., Portola Pharmaceuticals, Inc., resTORbio, Inc., Stemline Therapeutics, Inc., Taubman Centers, Inc. and Willis Towers Watson Public Limited Company and Wright Medical Group N.V.
PR Newswire · 05/28 15:11
Portola Pharmaceuticals Option Alert: Jan 15 $17.5 Puts Sweep (8) near the Bid: 504 @ $0.25 vs 7198 OI; Ref=$17.835
Benzinga · 05/22 14:34

Hot Stocks


Webull offers kinds of Portola Pharma stock information, including NASDAQ:PTLA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTLA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PTLA stock methods without spending real money on the virtual paper trading platform.